About
5th Gamma Delta T Therapies Summit - What's Was it About?
Gamma Delta T Therapies continued to spark interest whereby their unique biological features are being targeted to better tackle solid tumors. In 2024, the community was poised at a pivotal juncture, intensifying efforts to comprehensively grasp the clinical safety and efficacy of gamma delta T therapies. This summit aimed to solidify confidence in the transformative potential of this approach within the realms of cell therapy and antibody development.
Bootcamp
Day
Attendees explored past and present clinical insights to forecast future therapeutic directions, the potential of epigenetic reprogramming to maximize therapeutic efficacy, implementing best practices in manufacturing gamma delta T cells for quality, scalability, and safety in clinical applications
Research & Translational Development
Attendees explored how to fine tune mechanisms of gamma delta T cells for precise solid tumor targeting and treating autoimmune diseases
Clinical Development & Product Optimization
Attendees discovered the best practises when organising clinical trial design and appeasing regulators to fast track pipelines into the clinic and beyond
Scientific Poster Session
This was the attendees' opportunity to share their work and gain exposure for their research, and foster discussion with many of the brightest minds.
“There was an excellent mix of academia and drug developer folks, so this is a great venue of learning gdT cell biology and the progress of developing gdT cell therapies”
– Associate Principal Scientist, Merck & Co - Past Delegate